Research Overview: Stanomed 50 Swiss Med
Stanomed 50 Swiss Med is a laboratory-grade anabolic steroid preparation containing stanozolol, a synthetic derivative of dihydrotestosterone designed for comprehensive in-vitro research applications. This pharmaceutical-quality compound enables researchers to investigate anabolic-androgenic steroid mechanisms, protein synthesis pathways, and cellular response patterns in controlled laboratory environments. The preparation maintains consistent molecular integrity, making it suitable for advanced biochemical studies examining steroid receptor binding, metabolic processing, and downstream signalling cascades. Research institutions utilise this compound to evaluate anabolic effects on muscle tissue samples, analyse hormone receptor interactions, and study the molecular basis of performance-enhancing drug mechanisms.
Laboratory Applications and Research Potential
Scientific investigations with Stanomed 50 Swiss Med encompass diverse research areas including cellular metabolism studies, protein synthesis analysis, and anabolic pathway evaluation. Researchers examine this compound’s interactions with androgen receptors, studying binding affinity patterns and downstream gene expression changes in tissue cultures. The preparation facilitates investigations into muscle protein accretion mechanisms, nitrogen retention pathways, and cellular growth factor responses. Advanced studies utilise this material to analyse steroid metabolism, hepatic processing patterns, and enzymatic conversion pathways. Comparative research examines structure-activity relationships between different anabolic compounds, evaluating receptor selectivity and tissue-specific responses. Toxicology studies investigate cellular stress responses, oxidative damage patterns, and metabolic disruption mechanisms. Researchers at Stroid UK Shop access comprehensive materials for steroid research, while specialists studying stanozolol compounds benefit from pharmaceutical-grade preparations. Investigations complement broader research into selective androgen receptor modulators and peptide-based research compounds for comprehensive anabolic pathway analysis.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Stanozolol |
| Concentration | 50mg/ml |
| Molecular Formula | C21H32N2O |
| Molecular Weight | 328.5 g/mol |
| CAS Number | 10418-03-8 |
| Purity | Pharmaceutical Grade |
| Storage | Room Temperature, Dry Conditions |
| Solubility | Oil-based Solution |
Research Compliance and Laboratory Use
Stanomed 50 Swiss Med is manufactured exclusively for in-vitro research purposes and laboratory investigations. This compound is not intended for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must maintain proper laboratory protocols, storage conditions, and safety procedures when handling this material. All studies should comply with institutional research guidelines and ethical standards for anabolic steroid research.
